Literature DB >> 17667443

Sciatic nerve neurolymphomatosis - extent and therapy response assessment with PET/CT.

Klaus Strobel1, Katharina Fischer, Thomas F Hany, Rositsa Poryazova, Hans H Jung.   

Abstract

Neurolymphomatosis is a rare condition and may be the first and only manifestation of a non-Hodgkin lymphoma. We present the case of a 59-year-old patient with fluctuating gluteal pain for 5 years and progressive palsy of the left lower extremity, leading to severe walking difficulties. The neurologic examination revealed pronounced atrophy, flaccid paresis, and sensory loss in the area of innervation of the left sciatic nerve. Electroneuromyography showed a severe sensomotoric axonal lesion of the left sciatic nerve. Biopsy of the lesion revealed diffuse large B-cell lymphoma. Fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography was performed for staging, showing a high FDG uptake of the left sciatic nerve. FDG-positron emission tomography/computed tomography after six cycles of chemotherapy showed complete metabolic response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17667443     DOI: 10.1097/RLU.0b013e3180a1ac74

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  8 in total

1.  Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report.

Authors:  Sigal Grisariu; Batia Avni; Tracy T Batchelor; Martin J van den Bent; Felix Bokstein; David Schiff; Outi Kuittinen; Marc C Chamberlain; Patrick Roth; Anatoly Nemets; Edna Shalom; Dina Ben-Yehuda; Tali Siegal
Journal:  Blood       Date:  2010-04-05       Impact factor: 22.113

2.  [Neurolymphomatosis. Subacute sensorimotor polyneuropathy as a first sign of non-Hodgkin's B cell lymphoma].

Authors:  P P Urban; E Kaczmarek; I Wellach; R Brüning; N Brüllke; C Schulte; K Knop; J Weis
Journal:  Nervenarzt       Date:  2008-06       Impact factor: 1.214

3.  Progressive neurolymphomatosis with cutaneous disease: response in a patient with mycosis fungoides.

Authors:  Ramez Hanna; Gina A Di Primio; Mark Schweitzer; Carlos Torres; Adnan Sheikh; Santanu Chakraborty
Journal:  Skeletal Radiol       Date:  2013-03-27       Impact factor: 2.199

4.  Neurolymphomatosis on F-18 FDG PET/CT and MRI Findings: A Case Report.

Authors:  Chae Moon Hong; Sang-Woo Lee; Hong Je Lee; Bong Il Song; Hae Won Kim; Sungmin Kang; Shin Young Jeong; Byeong-Cheol Ahn; Jaetae Lee; Yee Soo Chae
Journal:  Nucl Med Mol Imaging       Date:  2010-12-10

5.  Evaluation of Avulsion-Induced Neuropathology in Rat Spinal Cords with 18F-FDG Micro-PET/CT.

Authors:  Ze-Min Ling; Ying Tang; Ying-Qin Li; Hao-Xuan Luo; Lin-Lin Liu; Qing-Qiang Tu; Li-Hua Zhou
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

6.  Diagnostic Yield of FDG-PET/CT, MRI, and CSF Cytology in Non-Biopsiable Neurolymphomatosis as a Heralding Sign of Recurrent Non-Hodgkin's Lymphoma.

Authors:  Faiq Shaikh; Aubrey C Chan; Omer Awan; Nivedita Jerath; Chandan Reddy; Salman A Khan; Michael M Graham
Journal:  Cureus       Date:  2015-09-09

7.  (18)F-FDG PET/CT in Neurolymphomatosis: Report of 3 Cases.

Authors:  Nguyen Xuan Canh; Ngo Van Tan; Tran Thanh Tung; Nguyen Truong Son; Simone Maurea
Journal:  Asia Ocean J Nucl Med Biol       Date:  2014

8.  Autopsy proven peripheral nervous system neurolymphomatosis despite negative bilateral sural nerve biopsy.

Authors:  Adolfo Ramirez-Zamora; Sarkis Morales-Vidal; Jasvinder Chawla; José Biller
Journal:  Front Neurol       Date:  2013-12-06       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.